<DOC>
	<DOCNO>NCT02777502</DOCNO>
	<brief_summary>The purpose propose study investigate effectiveness cannabidiol reduce marijuana seek non-treatment seek volunteer . Cannabidiol cannabinoid ( similar cannabis , marijuana ) present marijuana alters effect marijuana . Assess ability acute smoke CBD pretreatment reduce marijuana-seeking behavior increase price-elasticity marijuana demand .</brief_summary>
	<brief_title>Effects Cannabidiol Marijuana-seeking Humans</brief_title>
	<detailed_description>Participants ask participate total three choice session two week session day separate least two day . Each session day last approximately 8 hour . During study session participant ask smoke cigarette . Participants ask smoke marijuana cigarette . These cigarette may contain cannabidiol may ( placebo ) . Participants ask answer question drug make feel . Vitals sign ( blood pressure , heart rate , oxygen saturation ) measure use non-invasive ( external ) vitals monitor . Six sample take three session . Blood sample obtain via butterfly catheter place vein . Participants ask remain laboratory marijuana-related subjective physiological effect return original level record morning smoke first marijuana cigarette .</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<criteria>1 . Participants male female age 2145 yr . 2 . Must generally good health . 3 . Volunteers may meet DSM5 criterion current Cannabis Use Disorder currently treatment seek treatment substance use problem . 4 . An observed , temperaturetested urine specimen must test positive THC inclusion solely base selfreport . 1 . Psychiatric illness Cannabis Nicotine Use Disorder . Also exclusionary history suspicion psychosis indication behavior conducive compliance study protocol . 2 . Neurologic disease : structural brain abnormality ( e.g. , neoplasms ) , cerebrovascular disease , seizures , infectious disease , history neurological disease , head trauma result unconsciousness . 3 . Cardiovascular disease : edema , chest pain palpitation exertion drug use , myocardial infarction , systolic blood pressure great 160 less 95 mmHg , diastolic pressure great 95 mmHg . 4 . Pulmonary disease : obstructive pulmonary disease , apnea , cor pulmonale , tuberculosis , dyspnea , orthopnea , tachypnea ( &gt; 24 breath per minute ) . Current diagnosis treatment asthma . History asthma may allow , per study physician 's discretion . 5 . Systemic disease : e.g. , endocrinopathies , renal hepatic failure , active hepatitis ( liver function test &gt; 3x normal cutoff ) , myxedema , hypothyroidism , adrenocortical insufficiency , Cushing syndrome , chronic GI disease , AIDS autoimmune disease involve CNS . 6 . Current substance use disorder Cannabis Nicotine Use Disorder . 7 . Cognitively impairment indicate estimate IQ low 85 . Individuals unable give voluntary informed consent enrol . They neither intoxicate undergo withdrawal time screen consent . 8 . Recent experimental participation ( within past month ) . 9 . Pregnancy lactation . Females heterosexually active use ( selfreport ) medically approve birth control measure ( e.g. , sterilization , tubal ligation , birth control pill , abstinence , intrauterine device , barrier method , cervical cap combine spermicide ) eligible . Women breastfeed exclude . 10 . Individuals currently , intend seek , court mandate substance abuse treatment exclude . Finally , participant may withdraw study comply study protocol , test positive drug abuse marijuana routine urine screen decide participate study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>